Global Addison's Disease Therapeutics Market 2023-2027

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global addisons disease therapeutics market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global addisons disease therapeutics market 2017 - 2021 ($ million)
4.2 Therapy Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
4.3 End-user Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Therapy
6.1 Market segments
Exhibit 30: Chart on Therapy - Market share 2022-2027 (%)
Exhibit 31: Data Table on Therapy - Market share 2022-2027 (%)
6.2 Comparison by Therapy
Exhibit 32: Chart on Comparison by Therapy
Exhibit 33: Data Table on Comparison by Therapy
6.3 Oral drugs - Market size and forecast 2022-2027
Exhibit 34: Chart on Oral drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Oral drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Oral drugs - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Oral drugs - Year-over-year growth 2022-2027 (%)
6.4 Parenteral drugs - Market size and forecast 2022-2027
Exhibit 38: Chart on Parenteral drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Parenteral drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Parenteral drugs - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Parenteral drugs - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Therapy
Exhibit 42: Market opportunity by Therapy ($ million)

7 Market Segmentation by End-user
7.1 Market segments
Exhibit 43: Chart on End-user - Market share 2022-2027 (%)
Exhibit 44: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 45: Chart on Comparison by End-user
Exhibit 46: Data Table on Comparison by End-user
7.3 Hospitals and clinics - Market size and forecast 2022-2027
Exhibit 47: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
7.4 Diagnostic laboratories - Market size and forecast 2022-2027
Exhibit 51: Chart on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by End-user
Exhibit 55: Market opportunity by End-user ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 57: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 59: Chart on Geographic comparison
Exhibit 60: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 61: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 63: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 64: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 67: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 77: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 81: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 85: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 Japan - Market size and forecast 2022-2027
Exhibit 89: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.11 Canada - Market size and forecast 2022-2027
Exhibit 93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 97: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 98: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 99: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 100: Overview on factors of disruption
11.4 Industry risks
Exhibit 101: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 102: Vendors covered
12.2 Market positioning of vendors
Exhibit 103: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 104: Abbott Laboratories - Overview
Exhibit 105: Abbott Laboratories - Business segments
Exhibit 106: Abbott Laboratories - Key news
Exhibit 107: Abbott Laboratories - Key offerings
Exhibit 108: Abbott Laboratories - Segment focus
12.4 Actiza Pharmaceutical Pvt. Ltd.
Exhibit 109: Actiza Pharmaceutical Pvt. Ltd. - Overview
Exhibit 110: Actiza Pharmaceutical Pvt. Ltd. - Product/Service
Exhibit 111: Actiza Pharmaceutical Pvt. Ltd. - Key offerings
12.5 Akorn Operating Co. LLC
Exhibit 112: Akorn Operating Co. LLC - Overview
Exhibit 113: Akorn Operating Co. LLC - Product/Service
Exhibit 114: Akorn Operating Co. LLC - Key offerings
12.6 Amgen Inc.
Exhibit 115: Amgen Inc. - Overview
Exhibit 116: Amgen Inc. - Product/Service
Exhibit 117: Amgen Inc. - Key offerings
12.7 Amneal Pharmaceuticals Inc.
Exhibit 118: Amneal Pharmaceuticals Inc. - Overview
Exhibit 119: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 120: Amneal Pharmaceuticals Inc. - Key news
Exhibit 121: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 122: Amneal Pharmaceuticals Inc. - Segment focus
12.8 Bayer AG
Exhibit 123: Bayer AG - Overview
Exhibit 124: Bayer AG - Business segments
Exhibit 125: Bayer AG - Key offerings
Exhibit 126: Bayer AG - Segment focus
12.9 Bristol Myers Squibb Co.
Exhibit 127: Bristol Myers Squibb Co. - Overview
Exhibit 128: Bristol Myers Squibb Co. - Product/Service
Exhibit 129: Bristol Myers Squibb Co. - Key offerings
12.10 Eli Lilly and Co.
Exhibit 130: Eli Lilly and Co. - Overview
Exhibit 131: Eli Lilly and Co. - Product/Service
Exhibit 132: Eli Lilly and Co. - Key offerings
12.11 GlaxoSmithKline Plc
Exhibit 133: GlaxoSmithKline Plc - Overview
Exhibit 134: GlaxoSmithKline Plc - Business segments
Exhibit 135: GlaxoSmithKline Plc - Key offerings
Exhibit 136: GlaxoSmithKline Plc - Segment focus
12.12 Hikma Pharmaceuticals Plc
Exhibit 137: Hikma Pharmaceuticals Plc - Overview
Exhibit 138: Hikma Pharmaceuticals Plc - Business segments
Exhibit 139: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 140: Hikma Pharmaceuticals Plc - Segment focus
12.13 Merck and Co. Inc.
Exhibit 141: Merck and Co. Inc. - Overview
Exhibit 142: Merck and Co. Inc. - Business segments
Exhibit 143: Merck and Co. Inc. - Key news
Exhibit 144: Merck and Co. Inc. - Key offerings
Exhibit 145: Merck and Co. Inc. - Segment focus
12.14 Neurocrine Biosciences Inc.
Exhibit 146: Neurocrine Biosciences Inc. - Overview
Exhibit 147: Neurocrine Biosciences Inc. - Product/Service
Exhibit 148: Neurocrine Biosciences Inc. - Key offerings
12.15 Novartis AG
Exhibit 149: Novartis AG - Overview
Exhibit 150: Novartis AG - Business segments
Exhibit 151: Novartis AG - Key offerings
Exhibit 152: Novartis AG - Segment focus
12.16 Pfizer Inc.
Exhibit 153: Pfizer Inc. - Overview
Exhibit 154: Pfizer Inc. - Product/Service
Exhibit 155: Pfizer Inc. - Key news
Exhibit 156: Pfizer Inc. - Key offerings
12.17 Takeda Pharmaceutical Co. Ltd.
Exhibit 157: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 158: Takeda Pharmaceutical Co. Ltd. - Product/Service
Exhibit 159: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 160: Takeda Pharmaceutical Co. Ltd. - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 161: Inclusions checklist
Exhibit 162: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 163: Currency conversion rates for US$
13.4 Research methodology
Exhibit 164: Research methodology
Exhibit 165: Validation techniques employed for market sizing
Exhibit 166: Information sources
13.5 List of abbreviations
Exhibit 167: List of abbreviations

List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on Global addisons disease therapeutics market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Therapy - Market share 2022-2027 (%)
Exhibits 31: Data Table on Therapy - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Therapy
Exhibits 33: Data Table on Comparison by Therapy
Exhibits 34: Chart on Oral drugs - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Oral drugs - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Oral drugs - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Oral drugs - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Parenteral drugs - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Parenteral drugs - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Parenteral drugs - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Parenteral drugs - Year-over-year growth 2022-2027 (%)
Exhibits 42: Market opportunity by Therapy ($ million)
Exhibits 43: Chart on End-user - Market share 2022-2027 (%)
Exhibits 44: Data Table on End-user - Market share 2022-2027 (%)
Exhibits 45: Chart on Comparison by End-user
Exhibits 46: Data Table on Comparison by End-user
Exhibits 47: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibits 48: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibits 49: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
Exhibits 50: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
Exhibits 51: Chart on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibits 52: Data Table on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Chart on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibits 54: Data Table on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibits 55: Market opportunity by End-user ($ million)
Exhibits 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 57: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 59: Chart on Geographic comparison
Exhibits 60: Data Table on Geographic comparison
Exhibits 61: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 63: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 64: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 67: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 71: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 77: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 78: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 79: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 80: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 81: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 82: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 83: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 84: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 85: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 87: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 88: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 89: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 90: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 91: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 92: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 95: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 96: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 97: Market opportunity By Geographical Landscape ($ million)
Exhibits 98: Impact of drivers and challenges in 2022 and 2027
Exhibits 99: Overview on Criticality of inputs and Factors of differentiation
Exhibits 100: Overview on factors of disruption
Exhibits 101: Impact of key risks on business
Exhibits 102: Vendors covered
Exhibits 103: Matrix on vendor position and classification
Exhibits 104: Abbott Laboratories - Overview
Exhibits 105: Abbott Laboratories - Business segments
Exhibits 106: Abbott Laboratories - Key news
Exhibits 107: Abbott Laboratories - Key offerings
Exhibits 108: Abbott Laboratories - Segment focus
Exhibits 109: Actiza Pharmaceutical Pvt. Ltd. - Overview
Exhibits 110: Actiza Pharmaceutical Pvt. Ltd. - Product/Service
Exhibits 111: Actiza Pharmaceutical Pvt. Ltd. - Key offerings
Exhibits 112: Akorn Operating Co. LLC - Overview
Exhibits 113: Akorn Operating Co. LLC - Product/Service
Exhibits 114: Akorn Operating Co. LLC - Key offerings
Exhibits 115: Amgen Inc. - Overview
Exhibits 116: Amgen Inc. - Product/Service
Exhibits 117: Amgen Inc. - Key offerings
Exhibits 118: Amneal Pharmaceuticals Inc. - Overview
Exhibits 119: Amneal Pharmaceuticals Inc. - Business segments
Exhibits 120: Amneal Pharmaceuticals Inc. - Key news
Exhibits 121: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits 122: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits 123: Bayer AG - Overview
Exhibits 124: Bayer AG - Business segments
Exhibits 125: Bayer AG - Key offerings
Exhibits 126: Bayer AG - Segment focus
Exhibits 127: Bristol Myers Squibb Co. - Overview
Exhibits 128: Bristol Myers Squibb Co. - Product/Service
Exhibits 129: Bristol Myers Squibb Co. - Key offerings
Exhibits 130: Eli Lilly and Co. - Overview
Exhibits 131: Eli Lilly and Co. - Product/Service
Exhibits 132: Eli Lilly and Co. - Key offerings
Exhibits 133: GlaxoSmithKline Plc - Overview
Exhibits 134: GlaxoSmithKline Plc - Business segments
Exhibits 135: GlaxoSmithKline Plc - Key offerings
Exhibits 136: GlaxoSmithKline Plc - Segment focus
Exhibits 137: Hikma Pharmaceuticals Plc - Overview
Exhibits 138: Hikma Pharmaceuticals Plc - Business segments
Exhibits 139: Hikma Pharmaceuticals Plc - Key offerings
Exhibits 140: Hikma Pharmaceuticals Plc - Segment focus
Exhibits 141: Merck and Co. Inc. - Overview
Exhibits 142: Merck and Co. Inc. - Business segments
Exhibits 143: Merck and Co. Inc. - Key news
Exhibits 144: Merck and Co. Inc. - Key offerings
Exhibits 145: Merck and Co. Inc. - Segment focus
Exhibits 146: Neurocrine Biosciences Inc. - Overview
Exhibits 147: Neurocrine Biosciences Inc. - Product/Service
Exhibits 148: Neurocrine Biosciences Inc. - Key offerings
Exhibits 149: Novartis AG - Overview
Exhibits 150: Novartis AG - Business segments
Exhibits 151: Novartis AG - Key offerings
Exhibits 152: Novartis AG - Segment focus
Exhibits 153: Pfizer Inc. - Overview
Exhibits 154: Pfizer Inc. - Product/Service
Exhibits 155: Pfizer Inc. - Key news
Exhibits 156: Pfizer Inc. - Key offerings
Exhibits 157: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits 158: Takeda Pharmaceutical Co. Ltd. - Product/Service
Exhibits 159: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits 160: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits 161: Inclusions checklist
Exhibits 162: Exclusions checklist
Exhibits 163: Currency conversion rates for US$
Exhibits 164: Research methodology
Exhibits 165: Validation techniques employed for market sizing
Exhibits 166: Information sources
Exhibits 167: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global Addison's disease therapeutics market: Actiza Pharmaceutical Pvt. Ltd., Akorn Operating Co. LLC, Amneal Pharmaceuticals Inc., Bristol Myers Squibb Co., Neurocrine Biosciences Inc., Hikma Pharmaceuticals Plc, Merck and Co. Inc., Novartis AG, Pfizer Inc., Takeda Pharmaceutical Co. Ltd., GlaxoSmithKline Plc, Abbott Laboratories, Amgen Inc., Eli Lilly and Co., Biogen Inc., Boehringer Ingelheim International GmbH, Bio Techne Corp., Lupin Ltd., BTL Biotechno Labs Pvt. Ltd., and Bayer AG.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is expanding research into the development of regenerative therapy.`

According to the report, one of the major drivers for this market is special drug designations.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

• Actiza Pharmaceutical Pvt. Ltd.
• Akorn Operating Co. LLC
• Amneal Pharmaceuticals Inc.
• Bristol Myers Squibb Co.
• Neurocrine Biosciences Inc.
• Hikma Pharmaceuticals Plc
• Merck and Co. Inc.
• Novartis AG
• Pfizer Inc.
• Takeda Pharmaceutical Co. Ltd.
• GlaxoSmithKline Plc
• Abbott Laboratories
• Amgen Inc.
• Eli Lilly and Co.
• Biogen Inc.
• Boehringer Ingelheim International GmbH
• Bio Techne Corp.
• Lupin Ltd.
• BTL Biotechno Labs Pvt. Ltd.
• Bayer AG